Azab Mohammad is a director of Lisata Therapeutics Inc.
Person profile
Roles
Address
Dublin, California
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
LISATA THERAPEUTICS, INC.
11 Jan 24
4
Xenon Pharmaceuticals Inc.
20 Dec 23
4
DURECT CORP
23 Jun 23
4
Xenon Pharmaceuticals Inc.
2 Jun 23
4
LISATA THERAPEUTICS, INC.
11 Jan 23
4
Xenon Pharmaceuticals Inc.
13 Dec 22
4
LISATA THERAPEUTICS, INC.
16 Sep 22
3
LISATA THERAPEUTICS, INC.
16 Sep 22
4
Xenon Pharmaceuticals Inc.
29 Jun 22
4
DURECT CORP
17 Jun 22
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
9 Jan 24 | LSTA Lisata Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 19,480 | 0.00 | 58,680 |
19 Dec 23 | XENE Xenon Pharmaceuticals | Common Shares | Option exercise | Acquire M | No | No | 9.85 | 3,497 | 34.45 k | 74,225 |
19 Dec 23 | XENE Xenon Pharmaceuticals | Common Shares | Option exercise | Acquire M | No | No | 9.85 | 823 | 8.11 k | 70,728 |
19 Dec 23 | XENE Xenon Pharmaceuticals | Stock Option Common Shares | Option exercise | Dispose M | No | No | 9.85 | 3,497 | 34.45 k | 0 |
19 Dec 23 | XENE Xenon Pharmaceuticals | Stock Option Common Shares | Option exercise | Dispose M | No | No | 9.85 | 823 | 8.11 k | 0 |
21 Jun 23 | DRRX Durect | Stock Option Common Stock | Grant | Acquire A | No | No | 5.29 | 5,500 | 29.10 k | 5,500 |
2 Jun 23 | XENE Xenon Pharmaceuticals | Stock Option Common Shares | Grant | Acquire A | No | No | 38.96 | 18,475 | 719.79 k | 18,475 |
9 Jan 23 | LSTA Lisata Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 20,000 | 0.00 | 39,200 |